Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: AXSM) | Delayed: 156.07 -0.24 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.31 | 52 Week High | $15.74 | |||
| Open | $156.13 | 52 Week Low | $5.37 | |||
| Day High | $158.08 | P/E | N/A | |||
| Day Low | $154.24 | EPS | $0.00 | |||
| Volume | 832,348 | |||||
